Wednesday, February 14, 2007

Aastrom Biosciences Study Bone Regeneration With Stem Cell Therapy

Study Indicates Stem Cells help bone grow:

-- Aastrom Biosciences Inc., a developer of stem cell therapies, said Wednesday follow-up data on an early-to-midstage study indicated its tissue repair cells may help bone regeneration.
The 12-month follow-up showed that 18 of the 20 patients involved with severe long bone fractures had multiple bone bridges, which is a sign of bone regeneration. In all, 36 patients are involved in the follow-up, but only 20 have completed the 12-month period.

The patients all had fractures in either their tibia, femur or humerus bones which failed to heal with standard bone grafting and surgical treatments. [Thats a BIG stipulation for the trial AND the N is very small]

Shares of Aastrom rose 5 cents, or 3.5 percent, to $1.49 in morning trading on the Nasdaq.

The simple injection of autologous stem cells is correct in theory, but I'm skeptical of promising complete regeneration of a particular tissue. More research needs to be done on stem cells without the government butting in.

ASTM closed today's trading at $1.50 per share or up 6 cents. In after hours, trading down a penny.

No comments: